Found 7 matching trials
FFNP-PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast Cancer
PHASE2The goal of this research is to test the accuracy of PET/MRI imaging with 1...
Location
University of Wisconsin, Madison
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
PHASE2This phase II trial tests the accuracy of functional imaging (FFNP)-positro...
Location
Siteman Cancer Center at Washington University
18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy
PHASE2Purpose: The purpose of this study is to evaluate FFNP PET/MRI's utility fo...
Location
Multiple Locations
Biomarkers to Detect Endocrine Therapy Resistance
PHASE2This pilot observational study is being done to identify possible biomarker...
Location
UW Carbone Cancer Center
Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography
PHASE2The purpose of this study is to evaluate the uptake of a radioactive tracer...
Location
Washington University School of Medicine
Assessment of Progesterone Receptors in Breast Carcinoma by Positron Emission Tomography (PET) Using Fluoro Furanyl Norprogesterone (FFNP)
PHASE1The purpose of this study is to see if Positron Emission Tomography (PET) i...
Location
Washington University / Barnes-Jewish Hospital
Study of 18F-FFNP Breast PET/MRI
PHASE2This clinical trial will investigate an estrogen-regulated parameter as an ...
Location
UW Carbone Cancer Center